RN7SKP164

Across TCGA pan-cancer cohorts, RN7SKP164 RNA is linked to patient survival in 4 of 34 cancer types, making it the most broadly survival-associated RN7SKP164 data layer.

The strongest signal is observed in bladder urothelial carcinoma (BLCA), where higher RN7SKP164 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RN7SKP164 expression acts as an unfavorable survival marker, although some lineages such as ESCA and KIRP show a favorable association.

BLCA, LUAD, and ESCA are the cancer types where RN7SKP164 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BLCA	DFS	Tertile	All	0.159	0.625	.016	27	view →
LUAD	OS	Tertile	All	0.235	0.788	.005	27	view →
ESCA	OS	Tertile	III,IV	1.000	0.372	.033	12	view →
KIRP	DFS	Tertile	III,IV	1.000	0.309	.045	3	view →

Pink = unfavorable, green = favorable. Showing the 4 strongest of 4 lineages.

RN7SKP164–BLCA (DFS)

Open the BLCA breakdown →